<DOC>
	<DOCNO>NCT02346097</DOCNO>
	<brief_summary>The purpose study investigate `` optimal electrical resynchronization '' achieve target leave ventricular lead placement myocardial region late electrical activation combine post-implant pacemakersettings narrow pace QRS width cause excess improvement pump function heart ( leave ventricular ejection fraction ) Cardiac Resynchronization Therapy ( CRT )</brief_summary>
	<brief_title>Electrophysiological Optimization Left Ventricular Lead Placement CRT</brief_title>
	<detailed_description>Background : Cardiac resynchronization therapy ( CRT ) establish therapy patient leave ventricular ( LV ) ejection fraction ( EF ) &lt; 35 % , electrocardiogram ( ECG ) prolong QRS duration ( 1 ) . The treatment implement implant pacemaker three pace lead : One right atrium , one right ventricle ( RV ) one epicardial vein coronary sinus , thereby establish atrial-synchronized biventricular pace coordinate RV LV contraction . Despite convince effect CRT survival , symptom , LV function ( 2,3,4 ) much 30-40 % patient benefit clinically treatment , so-called non-responders ( 5,6 ) . Annually around 600 CRT-systems implant Denmark 3000 patient live CRT . The risk complication associate CRT-treatment considerable ( 7 ) , conservative estimate expense implant CRT-device DKK 80.000 . Consequently , cost CRT non-responders high , patient health economy . Potential correctable reason non-response CRT non-optimal LV lead position non-optimal pacemaker programming ( 5 ) . At Department Cardiology , Aarhus University Hospital , Skejby , clinical practice place LV lead non-apical postero-lateral region aim towards myocardial segment electrical activation occur second half QRS complex surface ECG . Retrospective study document improved response rate CRT LV lead place myocardial region late electrical activation without scar tissue ( 8,9 ) . Furthermore , lack electrical resynchronization CRT illustrate unchanged prolonged QRS duration associate poor clinical outcome ( 10 ) programming interventricular ( VV ) delay obtain narrow QRS-complex suggest increase CRT response rate ( 11,12 ) . A recent randomized control trial ( ImagingCRT ) conduct institution demonstrate image guide LV lead placement strategy target late mechanically activate myocardial segment ( assessed pre-implant echocardiography ) separate scar tissue ( determine pre-implant myocardial scintigraphy ) improve clinical response rate CRT ( data yet publish ) . This method potential become routine clinical practice LV lead placement institution . Aim hypothesis : We aim investigate optimal electrical resynchronization achieve target LV lead placement myocardial region late electrical activation determine systematic electrical mapping available epicardial vein combine post-implant VV electrical optimization narrow pace QRS width cause excess improvement LVEF CRT . We hypothesize cause excess increase LVEF 4 % , absolute increase LVEF 12 % compare absolute increase LVEF 8 % use image guide CRT-implantation strategy . Methods : All patient refer CRT Aarhus University Hospital , Skejby assess eligibility . Eligibility criterion outcomes measure elsewhere clinicaltrial.gov . Study Course : After write informed consent patient follow study course specify . The day implantation CRT follow investigation schedule : Echocardiography ( asses LV function dimension ) , cardiac CT-scan ( localize available epicardial vein ) , myocardial scintigraphy ( 82Rubidium positron emission tomography ( Rb-PET ) ) , determine extent distribution scar tissue LVEF ( 13,14 ) ) , blood sample clinical evaluation . The patient randomize EITHER imgaging guide placement LV lead target myocardial region late mechanical activation VV-interval setting program simultaneous biventricular pacing ( routine CRT-strategy arm ) OR LV lead placement guide procedural electrical mapping available cardiac vein target myocardial region late electrical activation combine VV electrical optimization day implantation achieve narrow paced QRS width ( intervention arm ) . The day implantation patient undergo high-pitch cardiac CT verify LV lead position ( 15 ) , pacemaker test , program VV-intervals echocardiographic atrioventricular ( AV ) optimization . One month implantation patient pacemaker test research nurse accord standard clinical practice . Six month CRT implantation follow investigation repeat : Echocardiography , clinical evaluation , pacemaker test blood sample . Rb-PET also repeat determine potential change myocardial perfusion LVEF . Thereafter patient attend standard control pacemaker every six month accord standard procedure . Power Calculations statistic : We hypothesize CRT-strategy target optimal electrical resynchronization result excess increase 4 % LVEF compare routine CRT-strategy , 8 % increase expect . To identify absolute increase LVEF achieve statistical power 80 % , study need sample size 98 patient , give standard deviation ( SD ) 7 % group , two-sided alpha value 0.05 . Furthermore , achieve statistical power &gt; 80 % margen noninferiority 20 % secondary endpoint clinical non-response CRT ( assume 75 % clinical response rate control group ) need sample size 116 patient ( give two-sided alpha value 0.05 % ) . Taking consideration expect loss follow-up approximately 5 % patient , include 122 patient . All analysis conduct accord intention-to-treat principle . Differences group test use Students t-test , normality demonstrate ; otherwise non-parametric test ( Mann-Whitney ) use . Categorical variable analyze χ2 test . A two-sided P- value &lt; 0.05 consider significant . Research Plan : The Department Cardiology , Aarhus University Hospital , capacity equipment conduct trial . The group investigator contribute deep long-lasting experience CRT-treatment 150 de-novo CRT-devices annually implanted institution . We plan enroll patient two half-year period . This study plan start February 2015 PhD program Charlotte Stephansen , MD . Charlotte Stephansen prime investigator charge include patient perform clinical evaluation image acquisition admission CRT implantation six month follow-up . She also charge analyze data study completion . The result publish peer-reviewed international journal , expect result least three paper . None investigator conflict interest declare . The study conduct accord principle Helsinki Declaration II . The study approve The Central Denmark Region Committees Health Research Ethics , report Danish Data Protection Agency , register ClinicalTrials.gov . Perspective : No prospective randomize trial previously investigate effect CRT treatment-strategy target optimal electrical resynchronization achieve guide LV lead placement myocardial region late electrical activation combine post-implant VV electrical optimization narrow pace QRS width . It expect method improves response CRT . The human economic cost CRT non-responders therefore expect reduce . If excess increase LVEF achieve study , possible prevent relieve invalidating symptom reduce mortality select heart failue patient future . The utility potential benefit participate study expect equalize risk exposure ionize radiation , possible side effect inconvenience patient . References : Please refer reference chapter</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Symptomatic heart failure ( New York Heart Association ( NYHA ) functional class II IV ) despite optimal medical therapy ECG leave bundle branch block QRS ≥ 120 m LVEF ≤ 35 % Age &gt; 40 year Written inform consent Patients indwell single dual chamber pacemaker pace QRS &gt; 180 m eligible enrollment . Expected lifetime &lt; 6 month Expected heartsurgery within next 6 month Recent ( &lt; 3 month ) myocardial infarction coronary artery bypass graft ( CABG ) Pregnant lactate No write informed consent Cardiac CT perform patient contraindicate , i.e . presence depress renal function ( estimate Glomerular Filtration Rate ( eGFR ) &lt; 30 ml ( milliters ) /minute ) , thyrotoxicosis case former serious reaction contrast medium .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Cardiac Resynchronization Therapy</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>Ejection Fraction</keyword>
	<keyword>Narrow</keyword>
	<keyword>Pacemaker</keyword>
	<keyword>Electrophysiology</keyword>
	<keyword>Electrical activation mapping</keyword>
	<keyword>Coronary Sinus</keyword>
	<keyword>Mapping</keyword>
	<keyword>QRS</keyword>
	<keyword>QRS width</keyword>
	<keyword>Pacing Interval</keyword>
	<keyword>Left Ventricular Lead</keyword>
	<keyword>Cardiac CT</keyword>
	<keyword>Echocardiography</keyword>
	<keyword>Myocardial Scintigraphy</keyword>
	<keyword>6 Minutes Walk Test</keyword>
	<keyword>Imaging</keyword>
	<keyword>Left ventricular ejection fraction</keyword>
	<keyword>Epicardial vein</keyword>
	<keyword>Resynchronization</keyword>
	<keyword>ImagingCRT</keyword>
	<keyword>Optimal electrical resynchronization</keyword>
	<keyword>Cardiac compute tomography</keyword>
</DOC>